Dr. Xinyu Zhang | Medicine and Dentistry | Best Researcher Award

Published on by Citation Awards

Dr. Xinyu Zhang | Medicine and Dentistry | Best Researcher Award

Sichuan University West China Hospital|China

Zhang Xinyu is a young clinician-scientist dedicated to advancing cardiovascular medicine through a blend of rigorous clinical training and translational research. Currently a doctoral candidate in cardiology at the West China School of Medicine and West China Hospital, Sichuan University, Zhang is pursuing cutting-edge investigations into immune mechanisms and metabolic regulation underlying heart disease. His career journey reflects both intellectual versatility and academic excellence. Having obtained dual undergraduate degrees in Medicine and English Language and Literature at Sichuan University, Zhang combines clinical acumen with strong communication skills, which have enabled him to contribute effectively to international scientific dialogue. His fast-tracked admission to graduate studies—bypassing competitive entrance examinations—highlights his outstanding academic record. As a master’s student, Zhang deepened his expertise in clinical cardiology before transitioning seamlessly to doctoral research, where he has published in top-tier journals, including the European Heart Journal and Journal of Nuclear Cardiology. Zhang’s oral presentations at the European Society of Cardiology (ESC) Congress and China Heart Congress demonstrate his recognition at both national and global levels. His ongoing research focuses on T-cell regulation, genetic cardiomyopathies, and multimodality cardiac imaging, positioning him as a promising researcher bridging basic science and clinical application in cardiology.

Publication Profile

ORCID

Education

Zhang Xinyu’s academic journey reflects consistent excellence across clinical medicine and interdisciplinary learning. His formal education at Sichuan University, where he pursued a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree alongside a Bachelor of Arts in English Language and Literature. This rare dual-degree pathway enriched his clinical training with strong analytical and communication skills, preparing him for participation in international academic exchanges. His exemplary academic performance earned him direct admission to graduate school without the national entrance examination, a privilege reserved for top-ranking students. Zhang completed his Master of Clinical Medicine in Cardiology at West China School of Medicine/West China Hospital, Sichuan University. During this period, he was immersed in both clinical practice and research, gaining exposure to cardiomyopathies, imaging, and heart failure studies. His work as a master’s student laid the foundation for high-impact publications and international conference participation. Zhang was again granted direct doctoral admission, entering the PhD program in Cardiology at the same institution. His current research employs advanced methods such as single-cell RNA sequencing to study immune dysregulation in dilated cardiomyopathy, with a broader aim of developing novel diagnostic and therapeutic strategies in cardiovascular disease.

Experience

Zhang Xinyu’s professional and research experience reflects a balance between clinical cardiology and translational science. During his undergraduate MBBS studies at Sichuan University, he underwent rigorous clinical rotations across multiple departments, gaining broad exposure to patient care. His dual degree in English also enhanced his ability to engage with international medical literature and research collaborations. As a master’s student in cardiology Zhang engaged deeply with clinical case studies, advanced diagnostic imaging, and rare cardiomyopathies, leading to several publications in peer-reviewed journals. He contributed to the identification of unique presentations, such as mitochondrial cardiomyopathy and transthyretin-related amyloidosis, with findings published in journals like the European Heart Journal and Journal of Nuclear Cardiology. Currently, as a doctoral candidate in cardiology, Zhang’s work focuses on immunometabolic regulation and novel biomarkers in dilated cardiomyopathy. He has presented original research at international forums, including the European Society of Cardiology (ESC) Congress and China Heart Congress, where his work on immune dysregulation and perioperative predictors of heart dysfunction attracted significant attention. Through these combined clinical, research, and academic experiences, Zhang has developed a strong expertise at the interface of patient care and cardiovascular research, shaping his career as an emerging physician-scientist.

Honors and Awards

Zhang Xinyu’s academic excellence and contributions to cardiology research have been consistently recognized through prestigious awards and honors. He is a recipient of the Sichuan University Second-Class Scholarship for both his master’s and doctoral studies, acknowledging his outstanding academic performance, research productivity, and leadership among peers. These scholarships reflect consistent placement within the top ranks of students in one of China’s leading medical schools. Zhang was awarded the “Outstanding Graduate Student” honor at Sichuan University, an accolade reserved for individuals who have demonstrated excellence in both academic achievements and contributions to scientific advancement. During his PhD, he successfully passed the Doctoral Mid-Term Academic Assessment with excellence, underscoring his strong research progress and academic rigor. Earlier, during his master’s program Zhang was similarly recognized with Second-Class Scholarships, awarded annually based on superior academic records, research output, and engagement in scholarly activities. These awards reflect not only Zhang’s sustained academic and clinical excellence but also his ability to contribute meaningfully to the advancement of cardiology. They also highlight the recognition he has earned from both faculty and peers as a promising physician-scientist and future leader in cardiovascular medicine.

Research Focus

Zhang Xinyu’s research lies at the intersection of cardiac immunology, cardiomyopathy, and advanced imaging. His doctoral work investigates the role of immune dysregulation in dilated cardiomyopathy (DCM), with a specific focus on CD4+ T-cell imbalance and CAMK4-driven glycolytic regulation. By applying cutting-edge single-cell RNA sequencing, Zhang aims to uncover molecular pathways that could serve as therapeutic targets and biomarkers for disease progression. Another dimension of his research involves novel biomarkers of immune regulation, particularly the role of PTPN22 in effector memory T-cell function. These findings have clinical relevance for improving diagnostic accuracy and predicting patient outcomes in DCM. Beyond immune mechanisms, Zhang has contributed to research on rare genetic and metabolic cardiomyopathies, including mitochondrial disorders and transthyretin amyloidosis. His studies demonstrate how multimodal imaging techniques such as Tc-99m PYP and MDP scintigraphy can detect early disease and guide management. Zhang is also engaged in perioperative and long-term outcomes of mitral valve surgery patients, with implications for surgical risk stratification and post-operative care. Through this multifaceted approach, Zhang’s research aims to bridge bench-to-bedside translation, combining molecular discovery with clinical application to improve diagnosis, treatment, and prognosis in complex cardiovascular diseases.

Publications

  • Multiple liver abscesses caused by Streptococcus intermedius – Hepatobiliary Surgery and Nutrition

  • Left ventricular hypertrophy with cardiomyocyte atrophy and extensive interstitial fibrosis: a mitochondrial cardiomyopathy – European Heart Journal

  • Tc-99m PYP scintigraphy identified multi-organ disease associated with transthyretin Phe64Ser mutation – Journal of Nuclear Cardiology

  • Serial Tc-99m MDP scintigraphy demonstrating increasing cardiac uptake over time in light-chain cardiac amyloidosis – Journal of Nuclear Cardiology

  • CD4+ T Cell Subsets and PTPN22 as Novel Biomarkers of Immune Dysregulation in Dilated Cardiomyopathy – International Journal of Molecular Sciences

Marius Iulian Mihailescu | Veterinary Medicine | Best Researcher Award

Published on by Citation Awards

Marius Iulian Mihailescu | Veterinary Medicine | Best Researcher Award

Spiru Haret University | Romania

Marius Iulian Mihailescu, PhD Eng., is an Associate Professor at Spiru Haret University’s Faculty of Engineering and Informatics in Bucharest. He specializes in cryptography and information security for complex, scalable systems, including searchable encryption, homomorphic encryption, lattice schemes, multi-party computation, zero-knowledge protocols, and blockchain-based security. As a cybersecurity project manager at the Institute for Computers, he leads security software analysis with blue/red teams and oversees a team of twelve developers, using AGILE/SCRUM, Waterfall, and RUP methodologies to implement solutions in C#, Java, Python, ASP MVC, and SQL Server. He also serves as a lecturer (hourly) at the University of Bucharest and Ovidius University, teaching topics such as distributed systems, software security, and communication forensics. Previously, at NILPRP’s Low Temperature Plasma Laboratory, he developed software for quantum computing, cryptography in plasma contexts, elliptic curve-secured SEM image analysis, and PlasmaPy-based tools. Throughout his career, Dr. Mihailescu has authored numerous journal articles, conference papers, and books, and directed continuing professional development programs. He holds a  focusing on applied cryptography over biometric data and two MSc degrees—in Information Security and Software Engineering—from the Military Technical Academy and the University of Bucharest.

Publication Profile

‪Marius Iulian Mihailescu‬ – ‪Google Scholar‬

Education

Dr. Marius Iulian Mihailescu completed his PhD , focusing on applied cryptography over biometric data. He earned two MSc degrees—one in Information Security and another in Software Engineering—from the “Ferdinand I” Military Technical Academy and the University of Bucharest, respectively. His academic training has equipped him with a solid foundation in designing and evaluating advanced cryptographic schemes for real-world applications, especially in biometric and cloud environments. Though the exact titles of his theses are not listed, his PhD work entailed rigorous research on biometric data protection through encrypted authentication systems. His MSc studies likely covered core topics in software design and security mechanisms in computing systems. Additionally, his earlier education included a Bachelor’s degree (or equivalent) in Computer Science, which enabled him to teach and research across a wide range of technical subjects—from functional and secure web programming to IoT and blockchain technologies. Overall, his academic trajectory spans from fundamental computer science and programming to applied cryptography and cybersecurity engineering, enriched by practical and educational roles.

Experience

Dr. Mihailescu has served as an Associate Professor at Spiru Haret University in Bucharest, teaching undergraduate courses in information security, functional programming, cloud computing fundamentals, and web application development; and graduate courses on IoT and information security management. He also directs the CAD – Computer Applications for Production Efficiency professional development program and oversees various international workshops on cybersecurity, blockchain, cloud, IoT, functional programming, and web technologies. Simultaneously, he works as a Cybersecurity Project Manager at the Institute for Computers in Bucharest, where he leads blue/red team security analyses, coordinates research and development projects, and manages a team of developers using AGILE, SCRUM, and Waterfall methodologies. His technical toolkit includes C#, Java, Python, ASP MVC, Infragistics, DevExpress, JavaScript, HTML5, and SQL Server. He lectured (hourly) at the University of Bucharest, teaching distributed systems and software development methods. He added a lecturing role at Ovidius University of Constanța, covering topics like communication forensics and software security for master’s students. Earlier in his career, as a researcher at the Low Temperature Plasma Laboratory (NILPRP), he implemented quantum computing and cryptography algorithms, elliptic curve-based SEM image processing, AES/RSA plasma data security, error handling in quantum algorithms, and software using PlasmaPy and specialized Python tools for spatial and fusion plasma research.

Honors and Awards

The CV provided does not list explicit awards or honors such as grants, prizes, or honors. However, implicit indicators of recognition include his authorship of multiple books—such as Advances to Homomorphic and Searchable Encryption and Cryptography and Cryptanalysis in Java—which suggests significant scholarly contributions in your field. Additionally, his role as a cybersecurity project manager leading large development teams and coordinating international educational workshops (e.g., on ethical hacking, blockchain, cloud, IoT) highlights professional distinction and the trust placed in him for leadership and curriculum development. Serving in academic positions across multiple universities (Spiru Haret, University of Bucharest, Ovidius University) also speaks to his standing in the academic community. His involvement in quantum-safe cryptography research at NILPRP, and management of continuing education programs (such as CAD for enterprise efficiency), further reflect recognition of his expertise. While specific awards aren’t indicated, Dr. Mihailescu’s publication record, leadership roles, and academic appointments collectively form a strong profile of professional and scholarly achievement.

Research Focus

Dr. Mihailescu’s research centers on applied cryptography and information security, with a focus on encryption schemes that enable functionality without compromising privacy—such as searchable encryption, homomorphic encryption, and functional encryption. He is also involved in lattice-based cryptography, multi-party computation, zero-knowledge proofs, and secure protocol design. In recent years, he has tackled the intersection of cryptography and emerging technologies, including blockchain, privacy-preserving authentication, biometrics, IoT security, and mechanism design. Specific research outcomes include searchable encryption with biometric authentication and authorization for cloud environments; blockchain-enhanced searchable encryption using elliptic curves; privacy-preserving access control via self-sovereign identity; behavior-based cybersecurity threat detection; and automated structure recognition in SEM images for quantum-safe applications. His work also addresses machine learning applications for cybersecurity and encryption methods in resource-constrained environments. A consistent theme across his work is designing practical cryptographic solutions that secure distributed systems, cloud infrastructure, IoT deployments, and biometric systems while maintaining usability and performance.

Publications

  • Automated Recognition of Structures in Scanning Electron Microscopy Images Using Specialized Algorithms in MATLAB and Python

  • Access Control Based on Self-Sovereign Identity

  • CRANE: A Genuine Framework based on Verifiable Searchable Encryption Security and Resource Constraints Balancing on Client Side

  • Unveiling Threats: Leveraging User Behavior Analysis for Enhanced Cybersecurity

  • A Searchable Encryption Scheme with Biometric Authentication and Authorization for Cloud Environments

  • Blockchain Search Using Searchable Encryption Based on Elliptic Curves

  • Customized Authorization Process for Cloud Computing and IoT Using Attribute-Based Encryption

Fabio Artosi | Medicine and Dentistry | Young Scientist Award

Published on by Citation Awards

Fabio Artosi | Medicine and Dentistry | Young Scientist Award

Università degli Studi di Roma|Italy

Dr. Fabio Artosi is an accomplished medical doctor, dermatologist, and researcher whose career spans clinical medicine, oncology, and translational dermatology. He demonstrated academic excellence early, graduating from the State Classical High School “Piero Gobetti” with top honors. He pursued a single-cycle Master’s degree in Medicine and Surgery at Tor Vergata University of Rome, achieving the highest grade with honors. His thesis on unknown-primary melanoma won the “Silvio Pisotre” award for best dermatology thesis. Licensed as a medical doctor and registered in the Province of Latina, Dr. Artosi embarked on a trajectory combining patient care, postgraduate research, and innovation in dermatology. He has held competitive scholarships in Medical Oncology (Federico II University of Naples) and Dermatology and Venereology (Tor Vergata University). Currently a PhD candidate in Medical-Surgical Biotechnologies and Translational Medicine, he is deeply engaged in real-world studies, clinical trials, and experimental research focusing on skin cancer, inflammatory dermatoses, and targeted biological therapies. Author of numerous peer-reviewed articles, he actively contributes to international conferences, delivering oral presentations on advanced therapeutic strategies. With a commitment to integrating scientific discovery into patient care, Dr. Artosi stands at the forefront of dermatological innovation, blending academic rigor with compassionate clinical practice.

Publication Profile

Artosi, Fabio – Author details – Scopus Preview

Education

Dr. Fabio Artosi completed his secondary education at the State Classical High School “Piero Gobetti” in Fondi, Italy, graduating with a diploma awarded with full marks, a testament to his excellence in humanities, languages, and analytical thinking. He then pursued his studies at the Tor Vergata University of Rome, where he obtained a single-cycle Master’s degree in Medicine and Surgery with the highest honors, earning praise for his experimental thesis on the characterization of unknown-primary melanoma in light of new therapeutic options, a multicenter study that combined rigorous research methodology with clinical application. Shortly after, he achieved his national medical license and was registered with the Medical Doctors’ Register of the Province of Latina. His postgraduate path began with a scholarship in Medical Oncology at the Federico II University of Naples, where he refined his expertise in the clinical management of oncological patients. He was subsequently selected for the specific training course in General Medicine, further broadening his clinical scope. Continuing his specialization, he received a postgraduate scholarship in Dermatology and Venereology at Tor Vergata University, where he remains actively engaged. Currently, as a PhD student in Medical-Surgical Biotechnologies and Translational Medicine, he focuses on experimental dermatology, translational oncology, and epidemiology, integrating research excellence with patient-centered car.

Experience

Dr. Artosi’s career integrates direct patient care with high-impact research. Following his medical qualification in 2020, he undertook a postgraduate scholarship in Medical Oncology at Federico II University of Naples, where he gained advanced clinical skills in tumor diagnosis, systemic therapies, and patient follow-up.He entered the General Medicine training program while securing a dermatology scholarship at Tor Vergata University, immersing himself in the management of complex dermatological cases including autoimmune, inflammatory, and neoplastic skin diseases.He has been actively involved in multicenter clinical trials on biologics, immunotherapies, and targeted dermatological treatments, contributing to studies on psoriasis, hidradenitis suppurativa, actinic keratosis, chronic urticaria, and skin cancer prevention. His clinical expertise is complemented by strong dermoscopic, histopathological, and research protocol development skills. Internationally recognized for his scientific contributions, Dr. Artosi has presented at major dermatology and oncology conferences, including SIDEMAST and ADOI congresses, often as an invited speaker. His research output covers both real-life clinical studies and translational investigations into molecular biomarkers, immune modulation, and drug response patterns. Currently, as a PhD researcher, he continues to merge clinical insights with laboratory innovation, aiming to improve therapeutic strategies and patient outcomes in dermatology and related fields.

Honors and Awards

Dr. Fabio Artosi completed his secondary education at the State Classical High School “Piero Gobetti” in Fondi, Italy, graduating with a diploma awarded with full marks, a testament to his excellence in humanities, languages, and analytical thinking. He then pursued his studies at the Tor Vergata University of Rome, where he obtained a single-cycle Master’s degree in Medicine and Surgery with the highest honors, earning praise for his experimental thesis on the characterization of unknown-primary melanoma in light of new therapeutic options, a multicenter study that combined rigorous research methodology with clinical application. Shortly after, he achieved his national medical license and was registered with the Medical Doctors’ Register of the Province of Latina. His postgraduate path began with a scholarship in Medical Oncology at the Federico II University of Naples, where he refined his expertise in the clinical management of oncological patients. He was subsequently selected for the specific training course in General Medicine, further broadening his clinical scope. Continuing his specialization, he received a postgraduate scholarship in Dermatology and Venereology at Tor Vergata University, where he remains actively engaged. Currently, as a PhD student in Medical-Surgical Biotechnologies and Translational Medicine, he focuses on experimental dermatology, translational oncology, and epidemiology, integrating research excellence with patient-centered care.

Research Focus

Dr. Artosi’s research lies at the intersection of dermatology, oncology, and translational medicine. His primary interests include the epidemiology, pathogenesis, and clinical management of skin cancers (both melanoma and non-melanoma), with an emphasis on prevention strategies, biomarker discovery, and personalized treatment. He has contributed significantly to studies evaluating biologic agents in psoriasis, hidradenitis suppurativa, and psoriatic arthritis, particularly in complex cases with metabolic or oncological comorbidities. A key part of his work addresses inflammatory skin disorders, integrating insights from immunology to optimize biologic and small-molecule therapy outcomes. He is also involved in real-world evidence studies, capturing treatment patterns, safety profiles, and patient-reported outcomes to inform clinical guidelines. His translational projects investigate molecular markers in tumor microenvironments, immune response modulation, and microbial colonization in chronic skin disease. Additionally, he has studied the dermatological manifestations of systemic diseases, including connective tissue disorders and HIV-associated conditions. With active roles in multicenter randomized controlled trials and investigator-initiated studies, Dr. Artosi is committed to bridging experimental science with practical dermatological care. His research goal is to develop therapeutic strategies that are both scientifically sound and clinically feasible, ultimately enhancing patient quality of life and long-term disease control.

Publications

Relationship between collagen disorders and hidradenitis suppurativa regarding two cases of Loeys-Dietz syndrome – European Journal of Pediatric Dermatology 
 A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients – Pharmaceuticals 
Mepolizumab induced palmoplantar psoriasis: A case report – World Journal of Clinical Cases 
Epidemiological and clinical analysis of exposure-related factors in non-melanoma skin cancer – Environmental Research 
Efficacy and safety of tildrakizumab in elderly patients – Journal of Dermatological Treatment 
Dermanyssus gallinae dermatitis in a young Italian woman – Italian Journal of Dermatology and Venereology 
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin – Pharmaceuticals 
Apremilast as a Potential Targeted Therapy for Metabolic Syndrome in Psoriasis

Mihaela Rusu | Materials Science | Citation Visionary in Industry Award

Published on by Citation Awards

Mihaela Rusu | Materials Science | Citation Visionary in Industry Award

Institute of Medical Engineering | Germany

Dr. Mihaela Rusu is a Romanian-born scientist specializing in polymer chemistry, biomaterials, and cardiovascular regenerative medicine in Romania, she pursued her undergraduate studies in chemistry and physics at the University of Bucharest. She earned her PhD at the Max Planck Institute for Colloids and Interfaces, Golm, Germany, with a thesis on thermoreversible polymers in polyelectrolyte multilayers. Her career spans both academia and industry, including leadership roles in multinational companies such as Koninklijke DSM, where she managed R&D projects in functional coatings, biodegradable polymers, and biomedical materials. She has also contributed as a consultant and evaluator for EU research and innovation programs. she has been deeply involved in postdoctoral and teaching roles at RWTH Aachen University and the Helmholtz Institute, focusing on myocardial infarction remodeling and targeted drug delivery systems. Her expertise bridges interdisciplinary areas, from material science and nanotechnology to biomedicine. Dr. Rusu has an extensive publication record. She actively collaborates internationally, mentors students, and participates in scientific project management. Fluent in Romanian and English, with working knowledge of German and Dutch, she continues to contribute to cutting-edge research at the intersection of materials science and medicine.

Publication Profile

‪Mihaela Rusu‬ – ‪Google Scholar‬

Education

Dr. Mihaela Rusu earned her degree in Chemistry and Physics from the University of Bucharest specializing in physical chemistry. She pursued doctoral studies at the Max Planck Institute for Colloids and Interfaces, Golm, Germany where she completed a PhD thesis titled “Phase Transition of Thermoreversible Polymers in Polyelectrolyte Multilayers.” During this period, she also attended two specialized modules on Biomimetic Systems at the International Max Planck Research School.  she advanced her training in polymer sciences by completing the Top Opleiding Polymeren courses (Modules A2/A3) at Eindhoven University of Technology in the Netherlands. she pursued postdoctoral research at the RWTH Aachen University Medical Faculty and Helmholtz Institute, focusing on cardiovascular biomaterials. she began postdoctoral studies at Helmut Schmidt University, Hamburg, within the Faculty of Electrical Engineering and Medical Engineering. Her education integrates interdisciplinary expertise spanning chemistry, polymers, nanotechnology, biomaterials, and biomedical engineering, giving her a strong foundation for innovative research at the interface of materials science and medicine.

Experience

Dr. Rusu began her career as a student assistant in electrochemistry at the University of Bucharest before becoming Project Manager and Quality Manager at S.C. Biotechnos S.A., Romania, overseeing structured water and cosmetic laboratories. she led patent implementation for Estee Lauder and coordinated structured water technology research with Heraklion University, Greece. In academia, she supervised MSc students at IMPRS Golm-Berlin. At Koninklijke DSM, Netherlands she managed interdisciplinary R&D projects, including biodegradable polymers for drug delivery, functional coatings, and regenerative medicine applications, and directed subsidiary projects such as “My Vitamin. she worked as a consultant for TNO Eindhoven and transitioned into biomedical research at RWTH Aachen University’s Institute for Molecular Cardiovascular Research  focusing on post-myocardial infarction remodeling. She coordinated Indo-German BMBF projects, mentored Erasmus Mundus students, and evaluated Horizon and Horizon Europe proposals. she has worked at the Helmholtz Institute on thermo-magnetic responsive biomaterials for targeted drug delivery. Her career demonstrates a unique blend of industrial innovation, academic research, and international collaboration.

Honors and Awards

Dr. Rusu’s career reflects recognition through high-impact research roles, scientific leadership, and EU-level contributions rather than conventional academic prize awards. She has been entrusted as an evaluator and rapporteur for the European Commission’s Horizon and Horizon Europe funding programs, highlighting her expertise and credibility in multidisciplinary research assessment. As a project leader and scientific manager at Koninklijke DSM, she coordinated cross-sector collaborations and innovative product developments that bridged industry and biomedical applications. Her leadership in Indo-German collaborations under the BMBF framework (IGSTC) fostered significant international scientific exchange. She has supervised and mentored numerous graduate, doctoral, and postdoctoral researchers, contributing to their professional growth and scientific output. Dr. Rusu has also been recognized as a program coordinator for international internships and exchange mentor for Erasmus Mundus students, enabling scientific capacity-building and cultural exchange. Her contributions are validated by the impact of her publications in materials science, biomaterials, and cardiovascular medicine. While her record emphasizes practical achievements, leadership, and innovation, her sustained involvement in high-level research evaluation panels signifies her as a respected figure in European and global scientific communities.

Research Focus

Dr. Mihaela Rusu’s research integrates polymer science, biomaterials engineering, and cardiovascular regenerative medicine. She specializes in thermo- and magneto-responsive biodegradable polymers for targeted drug delivery systems. Her work focuses on the design of fiber-based scaffolds that enable in vivo monitoring and on-demand drug release, with applications in tissue regeneration and controlled therapeutic delivery. She investigates the interface between biomaterials and cell membranes, exploring how drug release kinetics influence cellular responses. In cardiovascular medicine, she examines the role of the collagen matrix, chemokines, and chemokine receptors in ischemia/reperfusion injury and post-myocardial infarction tissue remodeling. Earlier in her career, she contributed significantly to functional coatings, biodegradable polymers for drug delivery, and nanostructured surface technologies in industrial R&D. Her interdisciplinary approach bridges nanotechnology, polymer physics, and biomedical engineering, with an emphasis on translating materials science innovations into clinical and industrial applications. She also engages in microscopy-based material characterization and the development of biomimetic surfaces for medical devices. Through international collaborations, particularly Indo-German and EU-funded projects, she advances knowledge on biomaterial–tissue interactions, aiming to improve patient outcomes in cardiovascular diseases and regenerative medicine.

Publications

  • Coil-to-Globule Transition of PNIPAM Graft Copolymers with Charged Side Chains

  • Adsorption of Novel Thermosensitive Graft-Copolymers: Core–Shell Particles Prepared by Polyelectrolyte Multilayer Self-Assembly

  • Biomechanical Assessment of Remote and Postinfarction Scar Remodeling Following Myocardial Infarction

  • Vitamin C as Scavenger of Reactive Oxygen Species During Healing After Myocardial Infarction

  • Recent Advancements of Specific Functionalized Surfaces of Magnetic Nano- and Microparticles as a Theranostics Source in Biomedicine

  • Neutrophils Modulate Fibroblast Function and Promote Healing and Scar Formation After Murine Myocardial Infarction

Rita Albergueiro | Physics and Astronomy | Best Researcher Award

Published on by Citation Awards

Rita Albergueiro | Physics and Astronomy | Best Researcher Award

ULS São João|Portugal

Rita Albergueiro is a Medical Physicist with a degree in Physics and a Master’s in Medical Physics from the University of Porto. She is currently working at Porto São João University Hospital Center as a Medical Physicist in the Nuclear Medicine Department. Rita is diligent, organized, and passionate about overcoming challenges and finding solutions. She is excited to contribute to optimizing existing techniques and researching new treatments and processes in Medical Physics.

Publication Profile

Orcid

Education

Rita holds a Master’s Degree in Medical Physics from the University of Porto’s Faculty of Sciences, where she achieved an average course grade. Her dissertation, “Personalized Voxel-Based Dosimetry in Ho-166 Hepatic Radioembolization: A Dose Uncertainty Study,” was conducted at Hospital de Santo António under Professor Dr. João Santos’ supervision and received a final grade. She also completed a Degree in Physics from the same university with a final course grade.

Experience

Rita has worked as a Medical Physicist at Porto São João University Hospital Center since September. Prior to this, she completed an internship in the Nuclear Medicine Department at Hospital de Santo António, where she gained practical experience with software tools like HERMES and Q-Suite. She also participated in dosimetric studies of holmium-166 and lutetium-177 therapeutic treatments. Rita has been tutoring physics and mathematics at Espaço D study center.

Honors and Awards

European Congress of Medical Physics at the 5th European Congress in Munich, Germany, Rita presented two poster presentations. The topics included the influence of OSEM reconstruction parameters on activity quantification in SPECT/CT imaging and dosimetric evaluation of holmium-166 hepatic radioembolization. EANM Congress She showcased her expertise at the EANM Congress in Hamburg, Germany, with a poster and an e-poster. Her presentations focused on the impact of reconstruction algorithms on digital PET/CT imaging and post-therapeutic dosimetric evaluation of holmium-166 hepatic radioembolization. AOCMP-SEACOMP Congress: Although not directly related to her award, Rita’s work aligns with the themes discussed at the  Asia-Oceania Congress of Medical Physics (AOCMP) and Southeast Asia Congress of Medical Physics (SEACOMP). The congress, held in Penang, Malaysia, emphasized revolutionizing patient care through medical physics.

Research Focus

Rita’s research focuses on Medical Physics, particularly in nuclear medicine. She investigates uncertainties in tumor dose determination during treatment with holmium microspheres and explores the impact of reconstruction algorithms on digital PET/CT imaging. Her research aims to optimize existing techniques and develop new treatments and processes in Medical Physics.

Publications

Impact of Reconstruction Algorithms on Digital PET/CT: Evaluating Small Pulmonary Nodules Post-Therapeutic Dosimetric Evaluation of 166Ho Hepatic Radioembolization: Software Impact on Tumor and Liver Doses.
Influence of OSEM reconstruction parameters and MC collimator modeling on 166Ho activity quantification in SPECT/CT imaging.
Yttrium-90 radioembolization: Assessing dose rates and radiation protection precautions.

Pronalis Tapfumaneyi | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Citation Awards

Pronalis Tapfumaneyi | Toxicology and Pharmaceutical Science | Best Researcher Award

Datlabs Pvt Ltd|Zimbabwe

Pronalis Tapfumaneyi is a dedicated pharmacist and researcher with a strong background in public health and pharmaceutics. She’s currently pursuing her Master’s in Public Health at Africa University and has a Master’s degree in Pharmaceutics from Rhodes University, where she graduated with distinction. Pronalis has experience in regulatory affairs, clinical research, and community service, and is committed to improving healthcare outcomes.

Publication Profile

Orcid

Education

Master of Public Health (MPH): Pronalis is currently pursuing her MPH degree at Africa University, focusing on public health aspects that can significantly impact communities.Master of Science (MSc) in Pharmaceutics: She earned her MSc degree in Pharmaceutics from Rhodes University, where she graduated with distinction. Her research expertise in pharmaceutics has equipped her with a deep understanding of drug development and delivery systems. Bachelor of Pharmacy (BPharm): Pronalis completed her BPharm degree at Rhodes University, laying a solid foundation for her future academic and professional pursuits in pharmacy and public health. Her academic achievements demonstrate her commitment to excellence in her field, and her research experience has prepared her to tackle complex problems in public health and pharmaceutics.

Experience

 Regulatory Affairs Pharmacist: Currently, Pronalis serves as a Regulatory Affairs Pharmacist at Datlabs (Pvt) Ltd, where she ensures compliance with regulatory requirements and oversees the development of new products. Regulatory Officer: Pronalis has also worked as a Regulatory Officer at the Medicines Control Authority of Zimbabwe, where she evaluated dossiers for regulatory compliance and issued registration certificates for medicines. Clinical Study Coordinator and Technician: At the Biopharmaceutics Research Institute, Pronalis coordinated clinical studies, managed study documents, and performed data analysis. Retail Pharmacist: Additionally, Pronalis has experience as a Retail Pharmacist at Medpoint Pharmacy, where she dispensed prescriptions, conducted health screenings, and advised patients on medication use. These experiences have equipped Pronalis with a broad understanding of the pharmaceutical industry, from research and development to regulatory affairs and patient care.

Honors and Awards

Dean’s Academic Merit List: Pronalis has been recognized for her outstanding academic performance, being included on the Dean’s Academic Merit List for her exceptional grades and scholarly contributions. Master of Science with distinction: She graduated with distinction in her Master of Science program, highlighting her academic excellence and research capabilities in her field. National Research Foundation (NRF) Innovation Scholarship: Pronalis was awarded a prestigious scholarship by the NRF to support her research endeavors, acknowledging her potential to make significant contributions to her field. Biopharmaceutics Research Institute Scholarship: She received a scholarship from the Biopharmaceutics Research Institute, further underscoring her research potential and academic achievements. Golden Key International Honor Society membership: Pronalis is a member of the Golden Key International Honor Society, an esteemed organization that recognizes academic excellence and leadership potential.

Research Focus

Public Health: Pronalis’s research in public health is geared towards understanding and addressing health challenges at the community level. This includes exploring strategies to enhance healthcare delivery, improve patient safety, and promote overall well-being. Pharmaceutics: Her work in pharmaceutics involves the study of drug formulation, delivery systems, and pharmacokinetics. Pronalis aims to develop effective and safe pharmaceutical products that meet the needs of diverse patient populations. Regulatory Affairs: Pronalis’s expertise in regulatory affairs ensures that pharmaceutical products and healthcare practices comply with relevant laws, regulations, and standards. This includes evaluating dossiers for regulatory compliance and ensuring that products meet safety and efficacy requirements. A significant aspect of her current research is her ongoing dissertation project, which investigates factors associated with reporting of adverse drug events among healthcare workers in Harare city polyclinics. Identify barriers and facilitators: Pronalis seeks to understand the factors that influence healthcare workers’ reporting of adverse drug events, including potential barriers and facilitators.

Publications

Solute–Vehicle–Skin Interactions and Their Contribution to Pharmacokinetics of Skin Delivery, which explores the delicate balance between      molecular properties of drugs, skin properties, and formulation properties in percutaneous absorption.
Science of, and insights into, thermodynamic principles for dermal formulations, published in Drug Discovery Today.
The Pandemic and Your Skin – Direct and Indirect Impact of COVID-19, examining the effects of COVID-19 on skin health.
Fitting Pharmacodynamic Data to the Emax Model to Assess the Inherent Potency of Topical Corticosteroids, a study on assessing potency of    topical corticosteroids.
Recent Advances and Future Prospective of Topical and Transdermal Delivery Systems, discussing advancements in topical and transdermal    drug delivery systems.